EP0939634A4 - Antagonistes du recepteur il-8 - Google Patents

Antagonistes du recepteur il-8

Info

Publication number
EP0939634A4
EP0939634A4 EP97938426A EP97938426A EP0939634A4 EP 0939634 A4 EP0939634 A4 EP 0939634A4 EP 97938426 A EP97938426 A EP 97938426A EP 97938426 A EP97938426 A EP 97938426A EP 0939634 A4 EP0939634 A4 EP 0939634A4
Authority
EP
European Patent Office
Prior art keywords
receptor antagonists
antagonists
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97938426A
Other languages
German (de)
English (en)
Other versions
EP0939634A1 (fr
Inventor
Deborah Lynn Bryan
John Gerald Gleason
Katherine L Widdowson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of EP0939634A1 publication Critical patent/EP0939634A1/fr
Publication of EP0939634A4 publication Critical patent/EP0939634A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP97938426A 1996-08-15 1997-08-15 Antagonistes du recepteur il-8 Withdrawn EP0939634A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2397296P 1996-08-15 1996-08-15
US23972P 1996-08-15
PCT/US1997/014582 WO1998006398A1 (fr) 1996-08-15 1997-08-15 Antagonistes du recepteur il-8

Publications (2)

Publication Number Publication Date
EP0939634A1 EP0939634A1 (fr) 1999-09-08
EP0939634A4 true EP0939634A4 (fr) 2001-02-21

Family

ID=21818184

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97938426A Withdrawn EP0939634A4 (fr) 1996-08-15 1997-08-15 Antagonistes du recepteur il-8

Country Status (3)

Country Link
EP (1) EP0939634A4 (fr)
JP (1) JP2000516620A (fr)
WO (1) WO1998006398A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0932405A4 (fr) 1996-06-27 2001-10-17 Smithkline Beckman Corp Antagonistes des recepteurs d'il-8
GB9908410D0 (en) * 1999-04-13 1999-06-09 Pfizer Ltd Pyridines
CO5170514A1 (es) * 1999-05-28 2002-06-27 Smithkline Beecham Corp Antagonistas de los receptores de la il-8 nistas del receptor de la il-8
AU2001250412A1 (en) * 2000-03-31 2001-10-08 Ipf Pharmaceuticals Gmbh Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using specific chemokine receptor analysis and the chemokine receptor-ligand interaction
AR041834A1 (es) 2002-10-29 2005-06-01 Smithkline Beecham Corp Compuesto de difenilurea sustituido con sulfonamida, composicion farmaceutica que lo comprende y su uso para preparar dicha composicion
JPWO2004074260A1 (ja) * 2003-02-21 2006-06-01 協和醗酵工業株式会社 ピリミジン誘導体
WO2005113534A2 (fr) 2004-05-12 2005-12-01 Schering Corporation Antagonistes de chimiokines cxcr1 et cxcr2
CN101495113A (zh) 2006-04-21 2009-07-29 史密丝克莱恩比彻姆公司 Il-8受体拮抗剂
US20090093451A1 (en) 2006-04-21 2009-04-09 Smithkline Beecham Corporation IL-8 Receptor Antagonists

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0392802A2 (fr) * 1989-04-11 1990-10-17 Beecham Group p.l.c. Préparation d'analogues de l'urée et leur emploi dans des maladies bronchiales, cérébro-vasculaires et neuronales
WO1994004499A1 (fr) * 1992-08-13 1994-03-03 The Upjohn Company Des cyanoguanidines, agents bloquants du canal potassium
WO1994022807A1 (fr) * 1993-04-07 1994-10-13 Neurosearch A/S Derives ureiques et amidiques et leur utilisation dans la regulation des canaux a potassium des membranes cellulaires
WO1995007934A2 (fr) * 1993-09-14 1995-03-23 Chiron Corporation Inhibiteurs de il8
EP0652228A1 (fr) * 1993-05-12 1995-05-10 American Cyanamid Company Uréthanes et urées qui indusent la formation des cytokmer
WO1996025157A1 (fr) * 1995-02-17 1996-08-22 Smithkline Beecham Corporation Antagonistes des recepteurs d'il-8

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05294935A (ja) * 1991-03-15 1993-11-09 Green Cross Corp:The アミノピリジン系化合物

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0392802A2 (fr) * 1989-04-11 1990-10-17 Beecham Group p.l.c. Préparation d'analogues de l'urée et leur emploi dans des maladies bronchiales, cérébro-vasculaires et neuronales
WO1994004499A1 (fr) * 1992-08-13 1994-03-03 The Upjohn Company Des cyanoguanidines, agents bloquants du canal potassium
WO1994004500A1 (fr) * 1992-08-13 1994-03-03 The Upjohn Company Cyanoguanidines utilisees comme inhibiteurs de canal de potassium
WO1994022807A1 (fr) * 1993-04-07 1994-10-13 Neurosearch A/S Derives ureiques et amidiques et leur utilisation dans la regulation des canaux a potassium des membranes cellulaires
EP0652228A1 (fr) * 1993-05-12 1995-05-10 American Cyanamid Company Uréthanes et urées qui indusent la formation des cytokmer
WO1995007934A2 (fr) * 1993-09-14 1995-03-23 Chiron Corporation Inhibiteurs de il8
WO1996025157A1 (fr) * 1995-02-17 1996-08-22 Smithkline Beecham Corporation Antagonistes des recepteurs d'il-8

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9806398A1 *

Also Published As

Publication number Publication date
WO1998006398A1 (fr) 1998-02-19
JP2000516620A (ja) 2000-12-12
EP0939634A1 (fr) 1999-09-08

Similar Documents

Publication Publication Date Title
IL127666A0 (en) IL-8 receptor antagonists
HUP9903922A3 (en) Il-8 receptor antagonists
EP0932405A4 (fr) Antagonistes des recepteurs d'il-8
IL134855A0 (en) Il-8 receptor antagonists
IL131004A0 (en) Il-8 receptor antagonists
IL125717A0 (en) Il-8 receptor antagonists
IL128501A0 (en) IL-8 receptor antagonists
EP1000017A4 (fr) Antagonistes du recepteur il-8
EP1019035A4 (fr) Antagonistes du recepteur d'il-8
EP0907362A4 (fr) Antagonistes des recepteurs d'il-8
EP0920417A4 (fr) Antagonistes du recepteur de l'il-8
IL131005A0 (en) Il-8 receptor antagonists
ZA988101B (en) IL-8 receptor antagonists
EP0923373A4 (fr) Antagonistes du recepteur d'il-8
EP0971908A4 (fr) Antagoniste de recepteurs d'il-8
EP0957907A4 (fr) Antagonistes du recepteur de l'il-8
EP0939634A4 (fr) Antagonistes du recepteur il-8
EP0934066A4 (fr) Antagonistes du recepteur de l'interleukine-8 (il-8)
EP0920253A4 (fr) Antagonistes du recepteur il-8
EP1039903A4 (fr) Antagonistes des recepteurs de l'interleukine-8
EP1047424A4 (fr) Antagonistes des recepteurs il-8
EP0948330A4 (fr) Antagonistes du recepteur d'il-8
IL140983A0 (en) Il-8 receptor antagonists
HUP9903949A3 (en) Il-8 receptor antagonists
HUP9904303A3 (en) Il-8 receptor antagonists

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990212

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE CH DE ES FR GB IT LI NL

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/44 A, 7A 61K 31/495 B, 7A 61K 31/505 B, 7A 61K 31/535 B, 7C 07D 211/56 B

A4 Supplementary search report drawn up and despatched

Effective date: 20010105

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): BE CH DE ES FR GB IT LI NL

17Q First examination report despatched

Effective date: 20021009

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20030220

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1022430

Country of ref document: HK